Feed Preview

ALS: Transposon de-silencing

ALS: Transposon de-silencing diagram by Lightspring, Shutterstock
Lightspring, Shutterstock

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Top 20 most recent papers
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology

Guideline on therapeutic use of repetitive transcranial magnetic stimulation: Useful but know the methods and limitations

Clinical Neurophysiology : Official Journal of the International Federation of Clinical NeurophysiologyJanuary 7, 2020
Robert Chen
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology

Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): An update (2014-2018)

Clinical Neurophysiology : Official Journal of the International Federation of Clinical NeurophysiologyJanuary 7, 2020
Jean-Pascal LefaucheurUlf Ziemann
21
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration

The first case of the TARDBP p.G294V mutation in a homozygous state: is a single pathogenic allele sufficient to cause ALS?

Amyotrophic Lateral Sclerosis & Frontotemporal DegenerationDecember 20, 2019
Lucia CorradoSandra D'Alfonso
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology

Computer-based echotexture comparison of muscles. Exploring innovative analyses of ultrasound images

Clinical Neurophysiology : Official Journal of the International Federation of Clinical NeurophysiologyDecember 15, 2019
Daniele CoraciLuca Padua
1
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration

The protective role of pre-morbid type 2 diabetes in patients with amyotrophic lateral sclerosis: a center-based survey in China

Amyotrophic Lateral Sclerosis & Frontotemporal DegenerationDecember 20, 2019
Linjing ZhangDongsheng Fan
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology

Safety and tolerability of navigated transcranial magnetic stimulation in a tumor patient with no bone flap

Clinical Neurophysiology : Official Journal of the International Federation of Clinical NeurophysiologyDecember 18, 2019
Hussein KandeelKeyoumars Ashkan
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology

Somatosensory high frequency oscillations: A useful tool to analyze cortical excitability?

Clinical Neurophysiology : Official Journal of the International Federation of Clinical NeurophysiologyDecember 17, 2019
Domenico Restuccia
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology

Altered effective connectivity network in patients with insular epilepsy: A high-frequency oscillations magnetoencephalography study

Clinical Neurophysiology : Official Journal of the International Federation of Clinical NeurophysiologyDecember 23, 2019
Chunli YinYuping Wang
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology

Mismatch negativity to different deviant changes in autism spectrum disorders: A meta-analysis

Clinical Neurophysiology : Official Journal of the International Federation of Clinical NeurophysiologyJanuary 19, 2020
Tzu-Ching ChenChia-Hsiang Cheng
1
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology

Behavioural and brain responses in cognitive trance: A TMS-EEG case study

Clinical Neurophysiology : Official Journal of the International Federation of Clinical NeurophysiologyDecember 18, 2019
O GosseriesS Laureys
4
1
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology

Thalamo-cortical network dysfunction in temporal lobe epilepsy

Clinical Neurophysiology : Official Journal of the International Federation of Clinical NeurophysiologyDecember 11, 2019
Giovanni AssenzaVincenzo Di Lazzaro
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology

Reply to "Technology in context: A holistic care approach"

Clinical Neurophysiology : Official Journal of the International Federation of Clinical NeurophysiologyDecember 17, 2019
Kathleen SeidelPhilippe Schucht
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology

Electrophysiological evidence for limited progression of the proprioceptive impairment in Friedreich ataxia

Clinical Neurophysiology : Official Journal of the International Federation of Clinical NeurophysiologyDecember 17, 2019
G NaeijeX De Tiège
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration

Equivalency and practice effects of alternative versions of the Edinburgh Cognitive and Behavioral ALS Screen (ECAS)

Amyotrophic Lateral Sclerosis & Frontotemporal DegenerationDecember 14, 2019
Emmet CostelloNiall Pender
5
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration

Respiratory measurements and airway clearance device prescription over one year in amyotrophic lateral sclerosis

Amyotrophic Lateral Sclerosis & Frontotemporal DegenerationDecember 12, 2019
R TattersallD Meldrum
4
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology

Practice-dependent motor cortex plasticity is reduced in non-disabled multiple sclerosis patients

Clinical Neurophysiology : Official Journal of the International Federation of Clinical NeurophysiologyDecember 11, 2019
Mario Stampanoni BassiEnnio Iezzi
1
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology

Conscious and unconscious expectancy effects: A behavioral, scalp and intracranial electroencephalography study

Clinical Neurophysiology : Official Journal of the International Federation of Clinical NeurophysiologyDecember 23, 2019
Camille RozierLionel Naccache
15
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology

Early focality and spread of cortical dysfunction in amyotrophic lateral sclerosis: A regional study across the motor cortices

Clinical Neurophysiology : Official Journal of the International Federation of Clinical NeurophysiologyJanuary 22, 2020
Thanuja DharmadasaMatthew C Kiernan
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology

An update on retinal prostheses

Clinical Neurophysiology : Official Journal of the International Federation of Clinical NeurophysiologyDecember 24, 2019
Lauren N AytonMatthew A Petoe
3
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology

Electrical impedance myography as a biomarker of inclusion body myositis: A cross-sectional study

Clinical Neurophysiology : Official Journal of the International Federation of Clinical NeurophysiologyDecember 23, 2019
Bhaskar RoyRichard J Nowak

See more papers from this feed

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

Aging Epidemiology

This feed focuses on epidemiology of aging and aging-related conditions, including Alzheimer’s disease, dementia, and age-associated cognitive impairment. Here is the latest research.

© 2020 Meta ULC. All rights reserved
/feed-previews/als-transposon-de-silencing/678c2a9d-06bc-426b-b1f3-a3e1d44e2440